We are live on
!
Find out more
MAM
Meeder Asset Management Portfolio holdings
AUM
$1.75B
1-Year Est. Return
34.85%
This Fund
S&P 500
This Quarter
Est. Return
+5.91%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.18B
AUM Growth
+$259M
(+28%)
Cap. Flow
+$204M
Cap. Flow
% of AUM
17.3%
Top 10 Holdings %
Top 10 Hldgs %
25.61%
Holding
1,947
New
328
Increased
686
Reduced
553
Closed
262
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$52.8M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$48.5M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$44.9M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$18.6M |
| 5 |
Vanguard Total Bond Market
BND
|
+$14.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$5.55M |
| 2 |
Fidelity National Financial
FNF
|
+$4.63M |
| 3 |
PPL
PPL Corp
PPL
|
+$4.41M |
| 4 |
S&P Global
SPGI
|
+$4.41M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$3.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.77% |
| 2 | Technology | 12.48% |
| 3 | Healthcare | 9.89% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Iovance Biotherapeutics
IOVA
$2.77B
| $9K | ﹤0.01% |
1,107
+871
| +369% | +$6.99K |
|
1152
Lipocine
LPCN
$17.6M
| $9K | ﹤0.01% |
148
+51
| +53% | +$3.17K |
|
1153
MiMedx Group
MDXG
$609M
| $9K | ﹤0.01% |
707
-936
| -57% | -$11.4K |
|
1154
Myers Industries
MYE
$1.32B
| $9K | ﹤0.01% |
452
+189
| +72% | +$3.96K |
|
1155
National CineMedia
NCMI
$378M
| $9K | ﹤0.01% |
134
-71
| -35% | -$4.72K |
|
1156
Onto Innovation
ONTO
$13.4B
| $9K | ﹤0.01% |
375
-78
| -17% | -$2.08K |
|
1157
Dave & Buster's
PLAY
$351M
| $9K | ﹤0.01% |
170
-309
| -65% | -$15.8K |
|
1158
Qualys
QLYS
$6.29B
| $9K | ﹤0.01% |
138
-301
| -69% | -$16.9K |
|
|
RGLS
1159
DELISTED
Regulus Therapeutics
RGLS
| $9K | ﹤0.01% |
75
+39
| +108% | +$4.94K |
|
1160
Regis Corp
RGS
$71.9M
| $9K | ﹤0.01% |
31
+9
| +41% | +$2.76K |
|
1161
Sterling Infrastructure
STRL
$16.4B
| $9K | ﹤0.01% |
563
+425
| +308% | +$7K |
|
1162
Tejon Ranch
TRC
$444M
| $9K | ﹤0.01% |
414
+105
| +34% | +$2.17K |
|
1163
Timberland Bancorp
TSBK
$355M
| $9K | ﹤0.01% |
332
+107
| +48% | +$3.1K |
|
1164
Travere Therapeutics
TVTX
$5.89B
| $9K | ﹤0.01% |
421
+296
| +237% | +$6.76K |
|
1165
Universal Logistics Holdings
ULH
$485M
| $9K | ﹤0.01% |
+370
| New | +$8.28K |
|
1166
Valhi
VHI
$453M
| $9K | ﹤0.01% |
113
-74
| -40% | -$4.24K |
|
|
EGRX
1167
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $9K | ﹤0.01% |
182
-660
| -78% | -$36.7K |
|
|
BFX
1168
DELISTED
BowFlex Inc.
BFX
| $9K | ﹤0.01% |
672
+617
| +1,122% | +$8.93K |
|
|
VRTV
1169
DELISTED
VERITIV CORPORATION
VRTV
| $9K | ﹤0.01% |
307
-51
| -14% | -$1.48K |
|
|
CDK
1170
DELISTED
CDK Global, Inc.
CDK
| $9K | ﹤0.01% |
125
-1,035
| -89% | -$69.5K |
|
|
FOE
1171
DELISTED
Ferro Corporation
FOE
| $9K | ﹤0.01% |
+373
| New | +$8.83K |
|
|
ZIXI
1172
DELISTED
Zix Corporation
ZIXI
| $9K | ﹤0.01% |
2,030
| – | – |
|
|
BOLD
1173
DELISTED
Audentes Therapeutics, Inc
BOLD
| $9K | ﹤0.01% |
289
+174
| +151% | +$4.78K |
|
|
CBM
1174
DELISTED
Cambrex Corporation
CBM
| $9K | ﹤0.01% |
178
+113
| +174% | +$5.6K |
|
|
FTD
1175
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $9K | ﹤0.01% |
1,343
+850
| +172% | +$7.9K |
|
Similar funds
SFI
DF
CIP
PWP
VCM
PAIM
RIA
NM
Meeder Asset Management's Q4 2017 Portfolio in Review
As of Q4 2017, Meeder Asset Management held 1,947 positions worth $1.18B, up 28% from $918M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Meeder Asset Management deployed $204M of net new capital in Q4 2017, opening 328 new positions and adding to 686 existing holdings. Its largest new stake was Vanguard Total Bond Market: 183,017 shares worth $14.9M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $5.55M trimmed.
- Meeder Asset Management's largest Q4 2017 buy was Vanguard Total Bond Market: 183,017 shares worth $14.9M.
- Meeder Asset Management added most to iShares 7-10 Year Treasury Bond ETF in Q4 2017, an estimated $52.8M increase.
- Meeder Asset Management's biggest Q4 2017 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $5.55M.
- Meeder Asset Management fully exited Fidelity National Financial in Q4 2017, selling an estimated $4.63M.
- Meeder Asset Management's ten largest holdings make up 26% of its $1.18B portfolio in Q4 2017.
- Meeder Asset Management opened 328 new positions and closed 262 in Q4 2017.
- Meeder Asset Management's portfolio value rose 28% quarter-over-quarter to $1.18B.
Based on Meeder Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.